Antiepileptic drug development: I. History and a program for progress.
D000927:Anticonvulsants / Q000266:history* / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D001965:Bromides / Q000266:history; D004339:Drug Compounding / Q000266:history*; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D049672:History, 19th Century; D049673:History, 20th Century; D007700:Kinetics; D009316:National Institutes of Health (U.S.); D010634:Phenobarbital / Q000266:history; D010672:Phenytoin / Q000266:history; D012109:Research Support as Topic; D013329:Structure-Activity Relationship; D014481:United States
D000927:Anticonvulsants; D001965:Bromides; D010672:Phenytoin; D010634:Phenobarbital